ORBIMED ADVISORS LLC 13D and 13G filings for Repare Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-11-02 5:01 pm Sale |
2021-11-01 | 13D | Repare Therapeutics Inc. RPTX |
ORBIMED ADVISORS LLC | 3,177,041 7.700% |
-99,284 (-3.03%) |
Filing |
| 2020-06-25 8:19 pm Purchase |
2020-06-19 | 13D | Repare Therapeutics Inc. RPTX |
ORBIMED ADVISORS LLC | 3,276,325 8.900% |
3,276,325 (New Position) |
Filing |